|
Managed Haemoglobinopathy Clinical Network
Newsletter No1 (July 2002) How it started • Stakeholders were worried that services for haemoglobinopathy patients (i.e. sickle cell disease & thalassaemia) were not uniform across Northwest London sector. Some patients are known to shop around for services. • Towards a vision of improved care, a public health consultation meeting was held on June 28, 2001 chaired by Dr Jim Kennedy, Medical Director Hillingdon Primary Care Trust. There were over 50 participants including senior clinicians, commissioners, and senior nursing professionals, counsellors, social workers, researchers, voluntary organisations, user groups and patient representatives. All the former four Health Authorities in Northwest London were represented. • It was agreed to establish a clinical network for Northwest London, with a Network Manager. • The four Directors of Public Health (DsPH) asked Dr Catherine Brogan Director Public Health Brent & Harrow Health Authority (BHHA) to lead the network. The Chief Executives of the four HAs agreed at their 2001 autumn meeting to fund the activities of the network in 2002 - 2004 (salaries for network manager, part-time PA support, GP training materials and public education) • In January 2002, BHHA advertised the post of Senior Clinical Medical Officer with special responsibilities for establishing the network, to develop an initial 2-year plan and a forward 5-year strategic plan. The network is part of the public health team in BHHA (Now Brent PCT) as most of the Patients are in Brent. • An interview was conducted for the network manager post on Feb 15, 2002. Interview panel included Dr Inderjeet Dokal – Consultant Haematologist Hammersmith Hospital / Ealing Hounslow & Hammersmith Health Authority; Dr Jean Chappell – National Neonatal Epidemiologist, Kensington Chelsea & Westminster Health Authority, and Dr Catherine Brogan – Director Public Health BHHA. • Dr Mabel Alli was offered the job of network manager. The network is now starting from 1 April 2002. Magnitude of the problem • Sickle cell disease (SCD) is common in black Africans and their worldwide descendants including African-Caribbean’s. Thalassaemia is common in a band of countries stretching from the Mediterranean to the Far East and can be found amongst people from these countries • SCD and Thalassaemia are genetically transmitted and the homozygotes have the disease. The heterozygotes have the trait and are usually healthy, but if their partners also carry the trait, there is a chance that some of their children could have the disease. Haemoglobinopathy carrier state has enormous clinical significance in future reproductive period. Aim of the network Objectives of the network Achievements so far • Watch out for the results of the audit in your next issue of the Newsletter, which will be in September 2002. Website links:
FOR MORE DETAILS PLEASE CONTACT |